oooooook.. had to organize my notes. no spell check or caps

New Post Public Reply Private Reply Replies (0) Message Board
joey68
oooooook.. had to organize my notes. no spell check or caps lock in this post. and.. this isn't short. Too much good stuff.

first off.. the chart is looking amazing. anyone notice we finally hit the EMA GOLDEN CROSS???? last time that happened we went to almost a penny. two times before that we went to a dime . I'm sure many new investors received a notice of SCIE crossing the golden cross today on their scanner software. how can we tell? volume. if it picks up in the next month or so, we'll know.

Be honest now... how many people actually read and understood the entire NT 10Q today? or did you find out it was delayed and got all poopie and disappointed?


Open up the 10Q again and read Part 3 real closely. oh come on, its YOUR INVESTMENT!

Quote:
3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof


SCIE checked No . This is great. This shows us clearly that nothing major changed in operations. Typically, I never want to see Yes checked at this stage. Personal opinion.

Now then, some people were questioning what the 10Q NT was talking about:

Quote:
As the result of the time required to calculate and review complex derivative accounting issues required to be included in the quarterly report on Form 10-Q....


This one sentence is the nuts and bolts of this entire post: "complex derivative accounting issues" is a fancy term for a contract being created between two parties which is based on assets.

So lets think.. what 'derivative' has spectrascience been dealing with which another party is also involved in?

This term "complex derivative accounting issues" is directly connected to Duke, Oncoscope, and Spectrascience. It's a fancy way for saying, "Spectrascience acquired Oncoscope's assets, some of these assets are being licensed by Duke..and... we sorta need a little more time to figure out all of the numbers and data before we post it in the real 10Q."

How do I know this? I didn't write about this for the past several weeks because there was no point, but I pretty much knew the 10Q was going to be delayed. how did I know? do I have a delorean time machine? yes, yes I do. but in addition to that, stocks which have had acquisitions followed soon after by a 10Q, very often delay the release of the 10Q due to the complexities involved in the numbers, financials, and complex derivative accounting issues. None of this means we're going to see a billion dollars in sales, but what this does show is that the acquisition between Oncoscope, SCIE, and the licensing with Duke is REAL. some naysayers a week ago were saying how no 8K was released which means theres no proof any of this stuff is real. Guess what.. it IS real and now we know.

I believe (feel free to disagree) today's candlestick is probably one of the most influential trading days SCIE has had in the past several months. All my opinion. Could I be wrong? Duh. But its my opinion and here's why:

This one candlestick, which by the way, closed green on the candle chart and elder chart, also created an EMA golden cross. I am convinced new investors are now aware of SCIE. In addition, the Bollinger bands have narrowed which shows low volatility. High volatility (a run) typically follows low volatility (happened up to .0092 last time) and its my belief that we are getting set up for a possible powder keg run past a penny. Anything above .0042 will ignite this and the squeeze north with begin. My opinion.

To top all of this, I found something that even SCIE didn't mention they were doing and its happening this Saturday :

http://www.ddw.org/

Go to Exhibitors > View list:

SCIE is attending DDW 2016. The last time they were at the LD Micro Invitational 2015 in Bel Air, CA, Michael oliver said sales were going to commence soon and that they were working on CREATING A NEW DEVICE, which would be around today, and this new device is more than likely Duke's tech for Barrett's esophagus.

Watch this video:

http://stocknewsnow.com/commentary/ANEWSID230...ience-Inc-

Go to 4:15
He talks about 'new products'. Guess what Duke's tech is for? NEW PRODUCTS.

When we get a PR about their new device, the share price will probably instantly jump.

Back to DDW 2016:

Notice Booth 3969 in the image below. That's Spectrascience!

See image:
whzDVlU.png
http://i.imgur.com/whzDVlU.png

Why is this important? because DDW is the world’s largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

Get it? Soak it in. The worlds LARGEST event of this type . and SCIE is there with only 270 or so other companies. Many of SCIE's competitors aren't on the list. but SCIE is!

DDW 2016 is THIS WEEKEND . AS IN THIS SATURDAY. Why is this so important? Companies don't spend the money attending these major (as in MAJOR) events unless they have something to offer.

Its happening right after the hopeful release of the 10Q.

SCIE also has the medtech 2017 event in January 2017 and SCIE;s logo is on the front webpage under JOHNSON AND JOHNSON! I truly believe this moment in the companies history is what they have been working towards for over a decade and I believe 2016 is going to be the start of staying over a penny and 2017 we will be over a dime or higher simply based off of the DD, the events SCIE is attending, the relationship with Duke, the acquisition, the interest in this tech.... its all coming together. Eventually, all of this is built up energy has to be released; and I believe its going to be released in the form of a run into multiple times or higher.


NOT INVESTMENT ADVICE. Do not invest based on this or any post. Do your own DD.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BC Mosaic App Store Unlocks New Tools for Researchers

Updated Category News Views 2

Unleashing Innovation Through Specialized Apps Oh boy, it's about time someone shook things up in the research game. BC Platforms has rolled out the BC Mosaic App Store, a move that's got research types buzzing from Zurich to... well, anywhere healthcare pokes its head. These guys aren't just throwing out some generic, run-of-the-mill tools. No sir, they've created a...

Continue Reading
Broadridge Expands Tokenization with G7 Securities

Updated Category News Views 9

Broadridge Takes a Big Step with G7 Integration Broadridge Financial Solutions is pulling no punches with its latest move—integrating G7 securities into its Distributed Ledger Repo (DLR) network. This isn't your average fintech maneuver; it's a heavyweight shift intended to redefine the way global financing and collateral markets work. Tokenized Repo: More Than Just a...

Continue Reading
Skanska's $57M Deal to Transform Del Mar Traffic

Updated Category News Views 5

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

Continue Reading
Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Updated Category News Views 4

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Continue Reading
Royal Mint Ventures Into the Final Frontier with Star Trek Coins

Updated Category News Views 1

A Cosmic Coin Collection for the Ages The Royal Mint has stepped boldly into a realm where no coin has gone before—celebrating six decades of Star Trek with two new collectable 50p coins. For Star Trek fans who’ve followed the Enterprise to the furthest reaches of the galaxy, these coins aren’t just chump change—they’re keepsakes that capture a piece of sci-fi...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading
BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Updated Category News Views 6

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Continue Reading
COFE Tech's $178M Pre-IPO Boost: Bold Move in MENA

Updated Category News Views 1

COFE Tech's Pre-IPO Raise: Scoring Big Dollars Today I'm reading this deal 'bout COFE Tech, and let me tell ya, there's more to chew over than a bowl of oatmeal. They just wrapped up a pre-IPO round at a hefty $178 million valuation. This wasn't just any ol' investment — we're talking about Wa'ed Ventures, the venture arm of Aramco, along with some heavy-hitter partners...

Continue Reading
Danielle D. Pollard Releases Game-Changing Exec Book

Updated Category News Views 0

Revolutionizing Communication Dynamics In a world where every word is scrutinized, Danielle D. Pollard's new book, Act Like a Lady, Speak Like a Wolf, arrives like a jolt of caffeine on a sleepy morning. With decades of engineering know-how and corporate grit, Pollard serves up a no-frills strategy to conquer the communication game, especially designed for women fighting...

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 0

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading

Top 5 Most Recently Viewed Articles

Dillard's, Inc. Financial Overview: Q3 and Yearly Insights

Updated Category News Views 332

Insights into Dillard's, Inc. Financial Performance Dillard's, Inc. (NYSE: DDS) has recently disclosed its operating results for the 13 and 39 weeks ending on a notable date. The retail landscape has faced challenges, which are reflected in the company’s sales data and overall performance metrics. CEO's Statement on Q3 Results William T. Dillard, II, the Chief Executive...

Continue Reading
Transforming Cannabis Consumption: The Rise of Vapes and Pre-Rolls

Updated Category News Views 84

The Evolution of Cannabis Consumption in Canada Recent equity research provides fascinating insights into the Canadian cannabis market. Analysts have observed a shift in consumer preferences, particularly noting a slowdown in the growth of recreational cannabis sales. This trend prompts questions about how consumption habits are evolving among Canadians. Current Market...

Continue Reading
Celebrating Music and Wine: The 10th Annual Festival Begins

Updated Category News Views 287

Celebrating a Milestone in Music and Wine At the heart of the Willamette Valley, the Appassionata Estate is set to host a special celebration as the 10th annual Willamette Valley Chamber Music Festival opens its doors once again. This festival is not just an event; it's a fusion of music, wine, and heartfelt community connections that folks have enjoyed for a decade. As...

Continue Reading
Transforming Data Control for Users with dFusion and VANA

Updated Category News Views 285

Empowering Users with Decentralized Data Ownership dFusion AI, in conjunction with VANA, has introduced a groundbreaking initiative known as the Private Social Lens Data Liquidity Pool (DLP). This innovative framework is set to revolutionize the way conversational data, particularly Telegram messages, is collected, validated, and monetized. This effort signifies a major...

Continue Reading
Guselkumab's Innovative Approval Revolutionizes Treatment Options

Updated Category News Views 199

Understanding the Advancement of Guselkumab Guselkumab is set to redefine treatment protocols for adults dealing with ulcerative colitis (UC) and Crohn's disease (CD), providing patients and healthcare providers with the convenience and flexibility of self-administration from the initiation of therapy. The introduction of TREMFYA® (guselkumab) allows for a fully...

Continue Reading